- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/30 - Oxygen atom attached in position 6, e.g. hypoxanthine
Patent holdings for IPC class C07D 473/30
Total number of patents in this class: 170
10-year publication summary
|
12
|
15
|
18
|
9
|
6
|
13
|
7
|
7
|
7
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 4147 |
7 |
| BeOne Medicines I GmbH | 371 |
7 |
| F. Hoffmann-La Roche AG | 7792 |
6 |
| Amgen Inc. | 4486 |
6 |
| Medivir AB | 112 |
6 |
| SHY Therapeutics LLC | 31 |
6 |
| Impetis Biosciences Ltd. | 31 |
6 |
| Merck Sharp & Dohme LLC | 3734 |
5 |
| Merck Sharp & Dohme Corp. | 2183 |
4 |
| AstraZeneca AB | 2826 |
4 |
| Takeda Pharmaceutical Company Limited | 2700 |
4 |
| Hoffmann-La Roche Inc. | 3849 |
3 |
| Auburn University | 498 |
3 |
| Tango Therapeutics, Inc. | 64 |
3 |
| Novartis AG | 10172 |
2 |
| The Regents of the University of California | 20924 |
2 |
| Pfizer Inc. | 3422 |
2 |
| Commissariat à l'énergie atomique et aux energies alternatives | 11136 |
2 |
| ATIR Holding S.A. | 16 |
2 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1452 |
2 |
| Other owners | 88 |